Picture of I-Mab logo

IMAB I-Mab Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for I-Mab, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line-1,452471-2,332-2,507
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items389189949812
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital185-241395552
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-868434-973-1,103
Capital Expenditures-12.2-8.01-29.9-45.8
Purchase of Fixed Assets
Other Investing Cash Flow Items225-194-697504
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities212-202-727458
Financing Cash Flow Items-0.8272,790-1390
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1533,44059442.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4883,565-1,235-213